PTC 治療公司
US ˙ NasdaqGS ˙ US69366J2006

SecurityPTCT / PTC Therapeutics, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership20,132 shares
Latest Disclosed Value $ 976,804
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 16.36% decrease in ownership of PTCT / PTC Therapeutics, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 20,132 shares of PTC Therapeutics, Inc. (US:PTCT) valued at $976,805 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 24,071 shares of PTC Therapeutics, Inc.. This represents a change in shares of -16.36% during the quarter. The current value of the position is $1,428,768 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP PTC THERAPEUTICS EC US69366J2006 20,132 -3,939 -16.36 977 -26.62 0.0129
2025-04-25 2025-02-28 NP PTC THERAPEUTICS EC US69366J2006 24,071 -715 -2.88 1,330 22.36 0.0179
2025-01-27 2024-11-30 NP PTC THERAPEUTICS EC US69366J2006 24,786 168 0.68 1,088 25.09 0.0147
2024-10-29 2024-08-31 NP PTC THERAPEUTICS EC US69366J2006 24,618 4,785 24.13 870 20.53 0.0129
2024-07-26 2024-05-31 NP PTC THERAPEUTICS EC US69366J2006 19,833 250 1.28 721 30.62 0.0114
2024-04-24 2024-02-29 NP PTC THERAPEUTICS EC US69366J2006 19,583 310 1.61 552 24.60 0.0092
2024-01-24 2023-11-30 NP PTC THERAPEUTICS EC US69366J2006 19,273 30 0.16 444 -41.71 0.0085
2023-10-27 2023-08-31 NP PTC THERAPEUTICS EC US69366J2006 19,243 1,481 8.34 760 2.01 0.0148
2023-07-26 2023-05-31 NP PTC THERAPEUTICS EC US69366J2006 17,762 54 0.30 745 -3.62 0.0161
2023-04-27 2023-02-28 NP PTC THERAPEUTICS EC US69366J2006 17,708 405 2.34 773 7.81 0.0189
2023-01-26 2022-11-30 NP PTC THERAPEUTICS EC US69366J2006 17,303 423 2.51 718 -14.85 0.0180
2022-10-26 2022-08-31 NP PTC THERAPEUTICS EC US69366J2006 16,880 603 3.70 843 76.15 0.0211
2022-07-29 2022-05-31 NP PTC THERAPEUTICS EC US69366J2006 16,277 468 2.96 478 -13.87 0.0122
2022-04-28 2022-02-28 NP PTC THERAPEUTICS EC US69366J2006 15,809 234 1.50 555 -3.98 0.0129
2022-01-25 2021-11-30 NP PTC THERAPEUTICS EC US69366J2006 15,575 387 2.55 579 -12.69 0.0121
2021-10-26 2021-08-31 NP PTC THERAPEUTICS EC US69366J2006 15,188 297 1.99 663 13.36 0.0145
2021-07-22 2021-05-31 NP PTC THERAPEUTICS EC US69366J2006 14,891 42 0.28 585 -31.05 0.0145
2021-04-23 2021-02-28 NP PTC THERAPEUTICS EC US69366J2006 14,849 -9,599 -39.26 848 -44.60 0.0221
2021-01-20 2020-11-30 NP PTC THERAPEUTICS EC US69366J2006 24,448 11,260 85.38 1,530 134.87 0.0457
2020-10-16 2020-08-31 NP PTC THERAPEUTICS EC US69366J2006 13,188 459 3.61 652 0.93 0.0201
2020-07-20 2020-05-31 NP PTC THERAPEUTICS EC US69366J2006 12,729 378 3.06 645 -4.73 0.0252
2020-04-24 2020-02-29 NP PTC THERAPEUTICS EC US69366J2006 12,351 468 3.94 677 21.33 0.0302
2020-01-16 2019-11-30 NP PTC THERAPEUTICS EC US69366J2006 11,883 11,883 558 0.0253
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.